Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-06-12

Clinical Trial Update: Flumazenil Reversal of Oral Triazolam [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial from the University of Washington evaluated whether flumazenil can reverse the effects of oral triazolam used for dental an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flumazenil (flumazenil)
  • HALCION (TRIAZOLAM)

Snippet

Sponsor: University of Washington | Conditions: Dental Anxiety | Phase 1, Phase 2 | Status: COMPLETED